Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

Clinical trial NCT00260039 · COMPLETED

Trial details

NCT number: NCT00260039
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HPV Cervical Cancer Premalignancy Anogenital Warts

Start date: 2005-12-01
Primary completion: 2007-08-01
Enrollment: 680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.